Benzo R, Flume P A, Turner D, Tempest M
Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston 29425, USA.
J Cardiopulm Rehabil. 2000 Jul-Aug;20(4):231-4. doi: 10.1097/00008483-200007000-00003.
Pulmonary rehabilitation (PR) is an accepted therapy for patients with chronic obstructive pulmonary disease (COPD), improving both exercise capacity and quality of life (QOL). Generic measures of QOL have been criticized as being insensitive to detecting the improvement in QOL after PR in contrast to disease-specific instruments. The authors looked at the Medical Outcomes Survey Short Form 36-item questionnaire (SF-36), a generic QOL measure, to detect changes in QOL in COPD patients after completion of PR.
Patients with COPD who participated in a PR program completed the QOL questionnaire before and after completion of PR. Exercise tolerance was assessed by the 6-minute walking test. Quality of life was assessed by the SF-36; the authors calculated its eight dimensions as well as mental (MCS) and physical (PCS) component summary scores.
The patients realized a significant improvement in exercise tolerance; 6-minute walking test distance increased from 470 +/- 104 m (mean +/- standard deviation) to 536 +/- 133 m (P = 0.0006) after PR. Quality of life also improved in nearly all dimensions and in both summary scores; PCS improved from 26.1 +/- 8.0 before PR to 30.5 +/- 9.0 after PR (P = 0.008) and MCS improved from 27.9 +/- 7.0 before PR to 34.1 +/- 5.0 after PR (P = 0.0002).
The SF-36 and its summary scores are sensitive instruments to detect improvement in QOL in COPD patients after PR.
肺康复(PR)是慢性阻塞性肺疾病(COPD)患者公认的治疗方法,可改善运动能力和生活质量(QOL)。与疾病特异性工具相比,通用的生活质量测量方法因对检测PR后生活质量的改善不敏感而受到批评。作者研究了通用生活质量测量方法——医学结局调查简表36项问卷(SF-36),以检测COPD患者完成PR后生活质量的变化。
参加PR项目的COPD患者在PR完成前后完成生活质量问卷。通过6分钟步行试验评估运动耐量。通过SF-36评估生活质量;作者计算了其八个维度以及心理(MCS)和身体(PCS)成分汇总得分。
患者的运动耐量有显著改善;PR后,6分钟步行试验距离从470±104米(平均值±标准差)增加到536±133米(P = 0.0006)。几乎所有维度以及两个汇总得分的生活质量也有所改善;PCS从PR前的26.1±8.0提高到PR后的30.5±9.0(P = 0.008),MCS从PR前的27.9±7.0提高到PR后的34.1±5.0(P = 0.0002)。
SF-36及其汇总得分是检测COPD患者PR后生活质量改善的敏感工具。